Autoimmune Diseases  >>  ramipril  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ramipril / Generic mfg.
NCT01225445: Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial

Completed
3
60
RoW
Ramipril
Chinese University of Hong Kong
Biopsy-confirmed IgA Nephropathy, Proteinuria Less Than 0.5 g Per Day, Normal Blood Pressure, Serum Creatinine Below 120 Umol/l
06/10
10/10
PREVENTKD, NCT00729365: (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)

Terminated
3
65
US
Ramipril, ACE Inhibitor, Placebo
Northwestern University, Juvenile Diabetes Research Foundation, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type 1 Diabetes
06/10
06/10

Download Options